Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

P. Chanson | A. Mamelak | R. Fahlbusch | F. Casanueva | M. Buchfelder | J. Loeffler | S. Samson | A. Formenti | S. Melmed | F. Keleştimur | E. Ghigo | A. Klibanski | M. Fleseriu | M. Bolanowski | M. Losa | M. Bidlingmaier | P. Caron | J. Abucham | M. Gadelha | A. Colao | F. Cordido | J. Bollerslev | M. Gurnell | L. Vilar | C. Boguszewski | C. Strasburger | G. Johannsson | G. Mazziotti | A. Shimatsu | A. Barkan | A. J. van der Lely | A. Lacroix | N. Tritos | B. Swearingen | B. Biller | Michael Pfeifer | A. Heaney | E. Laws | Y. Greenman | M. Reincke | P. Freda | N. Karavitaki | P. Mortini | D. Kelly | A. Hoffman | O. Bruno | M. Zatelli | A. Giustina | V. Popović | R. Salvatori | A. McCormack | M. Bronstein | G. Raverot | N. Biermasz | S. Neggers | A. Ben-Shlomo | S. Tsagarakis | I. Bernabéu | R. Villar-Taibo | C. Alvarez-Escola | P. Kadıoğlu | S. Petersenn | L. Katznelson | M. Mercado | V. Bonert | K. Ho | J. Carmichael | P. Trainer | A. Picó | M. Domingo | M. Kršek | A. Lomba | H. Fukuoka | G. Ning | M. Petakov | J. Wass | Ilan Shimon | I. Ilovayskaya | J. Jørgensen | Ashley Grossman | S. Mallea-Gil | L. De Marinis | Alin Abreu Julio Cristina Ariel L Albert Anat Ignacio M Lomba Abucham Alvarez-Escola Barkan Beckers | A. Beckers | Richard N. Clayton | E. Grineva | Jay StevenLoeffler | A. Luger | Nelson Oyesiku | Paul Stewart | N. Oyesiku | Michael Buchfelder | Andrea Giustina | J.A.H. Wass | Felipe F. Casanueva | Pietro Mortini | A. Barkan | A. Klibanski | Edward R. Laws | Albert Beckers | Vivien S. Bonert | Ken K. Y. Ho | F. Casanueva | E. Laws | J. Wass

[1]  Marko Šuica.  Serbia , 2019, The Palgrave Handbook of Conflict and History Education in the Post-Cold War Era.

[2]  A. V. van Beek,et al.  Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions , 2017, The Journal of clinical endocrinology and metabolism.

[3]  A. Formenti,et al.  Current and future medical treatments for patients with acromegaly , 2016, Expert opinion on pharmacotherapy.

[4]  A. Grossman,et al.  Quality indicators in pituitary surgery: a need for reliable and valid assessments. What should be measured? , 2016, Clinical endocrinology.

[5]  G. Vargas,et al.  Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. , 2014, The Journal of clinical endocrinology and metabolism.

[6]  P. Chanson,et al.  Expert consensus document: A consensus on the medical treatment of acromegaly , 2014, Nature Reviews Endocrinology.

[7]  R. Knutzen.  Pituitary centers of excellence: for patients it is life or death. , 2014, Neurosurgery.

[8]  T. Schwartz.  A role for centers of excellence in transsphenoidal surgery. , 2013, World neurosurgery.

[9]  D. Mazzatenta,et al.  Pituitary centers of excellence. , 2013, Neurosurgery.

[10]  Lai Wei,et al.  Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  E. Laws,et al.  Pituitary centers of excellence. , 2012, Neurosurgery.

[12]  B. Swearingen.  Update on pituitary surgery. , 2012, The Journal of clinical endocrinology and metabolism.

[13]  H. Shih,et al.  Radiation therapy in the management of pituitary adenomas. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  A. Kassam,et al.  Management of Cushing's Disease After Failed Surgery - A Review , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[15]  M. Guiot,et al.  Double Myxopapillary Ependymomas of the Filum Terminale , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  B. Scheithauer,et al.  Biomarkers of Pituitary Neoplasms: A Review (Part II) , 2010, Neurosurgery.

[17]  E. Laws,et al.  Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression. , 2010, The Journal of clinical endocrinology and metabolism.

[18]  Dennis C. Shrieve,et al.  Human Radiation Injury , 2010 .

[19]  A. Kassam,et al.  The role of outcomes data for assessing the expertise of a pituitary surgeon , 2010, Current opinion in endocrinology, diabetes, and obesity.

[20]  P. Chanson,et al.  Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. , 2010, Endocrine-related cancer.

[21]  Alberto Fernández,et al.  Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.

[22]  J. Janowsky,et al.  Cognition is not modified by large but temporary changes in sex hormones in men. , 2009, The Journal of clinical endocrinology and metabolism.

[23]  A. Beckers,et al.  The epidemiology and genetics of pituitary adenomas. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[24]  P. Chanson,et al.  Guidelines for acromegaly management: an update. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  M. Grady,et al.  Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve. , 2008, Neurosurgical focus.

[26]  D. McArthur,et al.  PITUITARY HORMONAL LOSS AND RECOVERY AFTER TRANSSPHENOIDAL ADENOMA REMOVAL , 2008, Neurosurgery.

[27]  Joshua R. Dusick,et al.  THE ENDONASAL MICROSCOPIC APPROACH FOR PITUITARY ADENOMAS AND OTHER PARASELLAR TUMORS: A 10‐YEAR EXPERIENCE , 2008, Neurosurgery.

[28]  E. Hedley‐Whyte,et al.  Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. , 2008, Human pathology.

[29]  M. Carson,et al.  Wide variation in surgical outcomes for acromegaly in the UK , 2008, Clinical endocrinology.

[30]  P. Gardner,et al.  Acquisition of Surgical Skills for Endonasal Skull Base Surgery: A Training Program , 2007, The Laryngoscope.

[31]  Michael Buchfelder,et al.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. , 2007, European journal of endocrinology.

[32]  PhD George Kontogeorgos MD.  Classification and pathology of pituitary tumors , 2007, Endocrine.

[33]  W. Pories,et al.  The ASBS Bariatric Surgery Centers of Excellence program: a blueprint for quality improvement. , 2006, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[34]  P. Cappabianca,et al.  Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas , 2006, Clinical endocrinology.

[35]  F. Esposito,et al.  Suboptimal Sphenoid and Sellar Exposure: A Consistent Finding in Patients Treated with Repeat Transsphenoidal Surgery for Residual Endocrine-inactive Macroadenomas , 2006, Neurosurgery.

[36]  O. Dilek,et al.  The learning curve in endoscopic pituitary surgery and our experience , 2006, Neurosurgical Review.

[37]  D. O’Rourke,et al.  Resident training in neurosurgical oncology: results of the survey of North American training programs by the AANS/CNS Section on Tumors , 2006, Journal of Neuro-Oncology.

[38]  Xianquan Zhan,et al.  Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. , 2005, Cancer research.

[39]  C. Ersoy,et al.  Outcome of Surgery for Acromegaly Performed by Different Surgeons: Importance of Surgical Experience , 2005, Pituitary.

[40]  J. Champion,et al.  Centers of Excellence for Bariatric Surgery. , 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[41]  R. Sergott,et al.  Fractionated stereotactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes , 2005, British Journal of Ophthalmology.

[42]  N. Kohara,et al.  BENEFITS AND RISKS OF ELECTRONIC PATIENT RECORDS ON THE WORKS OF THE PHARMACEUTICAL DEPARTMENT IN THE NATIONAL HOSPITAL ORGANIZATION, KYOTO MEDICAL CENTER , 2005 .

[43]  W. Curry,et al.  Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. , 2005, Neuro-oncology.

[44]  M. Losa,et al.  Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. , 2005, Neurosurgery.

[45]  A. Klibanski,et al.  Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. , 2003, The Journal of clinical endocrinology and metabolism.

[46]  E. Laws,et al.  Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. , 2003, Neurosurgical focus.

[47]  P. Chanson,et al.  Guidelines for acromegaly management. , 2002, The Journal of clinical endocrinology and metabolism.

[48]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[49]  E. Laws,et al.  The surgical management of pituitary adenomas in a series of 3,093 patients. , 2001, Journal of the American College of Surgeons.

[50]  D. Brat,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Novel Patterns of Gene Expression in Pituitary Adenomas Identified by Complementary Deoxyribonucleic Acid Microarrays and Quantitative , 2000 .

[51]  E. Laws,et al.  Radiosurgery for Cushing's disease after failed transsphenoidal surgery. , 2000, Journal of neurosurgery.

[52]  C. Weisman,et al.  Women's health centers: are the National Centers of Excellence in Women's Health a new model? , 2000, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[53]  J. Klose,et al.  Survey on neurosurgery subspecialty fellowship training , 1999 .

[54]  P. Stewart,et al.  Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon. , 1999, QJM : monthly journal of the Association of Physicians.

[55]  A. Yamaura,et al.  Transsphenoidal reoperations for removal of pituitary adenomas: rhinological management and timing of reoperation , 1999, Journal of Clinical Neuroscience.

[56]  Stratton,et al.  Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience , 1999, Clinical endocrinology.

[57]  Ciric Ivan,et al.  Complications of Transsphenoidal Surgery: Results of a National Survey, Review of the Literature, and Personal Experience. , 1997, Neurosurgery.

[58]  S. Sawano,et al.  Retrospective analysis of long‐term surgical results in acromegaly: preoperative and postoperative factors predicting outcome , 1996, Clinical endocrinology.

[59]  E. Laws,et al.  Transsphenoidal surgery following unsuccessful prior therapy. An assessment of benefits and risks in 158 patients. , 1985, Journal of neurosurgery.

[60]  A. Enthoven,et al.  Should operations be regionalized? The empirical relation between surgical volume and mortality. , 1980, The New England journal of medicine.

[61]  J. Schiffer,et al.  [Surgical management of pituitary tumors]. , 1971, Harefuah.

[62]  C. Cope.  ENDOCRINOLOGY AND NUTRITION , 1959 .